• ENDA/EAACI 2016: Drug allergy passport and other documentation for patients with drug hypersensitivity – An ENDA/EAACI Drug Allergy Interest Group Position Paper
• ENDA/EAACI 2016: In vitro tests for Drug Hypersensitivity Reactions. An ENDA/EAACI Drug Allergy Interest Group Position Paper (2016)
• NICE 2014 : Diagnosis and management of drug allergy in adults, children and young people
• ICON 2014: International Consensus on Drug Allergy
  
• WAO 2013: Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy
• EAACI 2013: Desensitization in delayed drug hypersensitivity reactions — an EAACI position paper of the Drug Allergy Interest Group
• EAACI 2013: Skin test concentrations for systemically administered drugs — an ENDA/EAACI Drug Allergy Interest Group position paper
• EAACI 2013: Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*
• SFAR 2011: Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice
• AAAAI 2010: Drug allergy: an updated practice parameter
• EAACI 2010: General considerations on rapid desensitization for drug hypersensitivity – a consensus statement
• BSACI 2009: BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia 
• BSACI 2009: BSACI guidelines on the management of drug allergy
• EAACI 2009: Update on evaluation of hypersensitivity reactions to betalactams
• EAACI/GA²LEN guideline 2007: Aspirin provocation tests for diagnosis of aspirin hypersensitivity
• EAACI 2005: Management of hypersensitivity reactions to iodinated contrast media
• EAACI 2003: Diagnosis of immediate allergic reactions to beta-lactam antibiotics
• EAACI 2003: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations
• EAACI 2002: General Considerations for Skin Tests Procedures in the Diagnosis of Drug Hypersensitivity